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Prosthesis size and prosthesis-
patient size are unrelated to
prosthesis-patient mismatch
To the Editor:
We read with interest the report of Black-
stone and colleagues1 published in the Sep-
tember 2003 issue of the Journal, as well as
the editorial of Gillinov and coworkers2 in
the August 2003 issue. The implicit con-
clusion of these two articles was that pros-
thesis-patient mismatch (PPM) is a rare
occurrence after aortic valve replacement
and that it has a negligible impact with
regard to postoperative outcomes. To de-
fine PPM and analyze its consequences,
both sets of authors chose, however, to use
an indexed area based on the internal geo-
metric dimension of the prosthesis divided
by the patient’s body surface area, rather
than the indexed effective orifice area,
which is the physiologic parameter most
often used to define PPM. They justified
their choice of parameter on the basis that
geometric measures “are determined before
implantation, have much less variability,
and are independent of hemodynamic
state.”1
The physiologic and clinical relevance
of the indexed internal geometric area as
used by these authors must, however, be
challenged. Indeed, it has never been
shown that this parameter can be related, in
any significant manner, to transvalvular
pressure gradients; in particular, it has been
demonstrated that the indexed internal geo-
metric orifice area cannot be used to predict
which patients will have high postoperative
3gradients. Inherent to the pathophysiology
1852 The Journal of Thoracic and Cardiovof valve PPM is the concept that too small
a prosthesis in too large a patient will pro-
duce abnormally high gradients and thus
have potentially detrimental consequences
such as might occur with a native aortic
stenosis. Thus if the indexed internal geo-
metric area cannot be related to postoper-
ative gradients, we do not see how it can
logically be used to identify PPM or to
characterize its severity.
In contrast, and despite its inherent lim-
itations, the indexed effective orifice area is
the only parameter that has consistently
been shown to correlate with postoperative
gradients, as well as being highly predic-
tive of adverse outcomes.3-5 Indeed, when
the definition of PPM is based on this pa-
rameter, the phenomenon has been shown
to be highly prevalent (19%-70%, depend-
ing on series4,5) and to be associated with
less symptomatic improvement, worse he-
modynamics at rest and during exercise,
less regression of left ventricular hypertro-
phy, and more cardiac events after opera-
tion.4,5 A recent report from our own lab-
oratory has clearly shown that PPM has a
major impact on early mortality, particu-
larly in patients with poor left ventricular
function and that, in contrast to other risk
factors, it can easily be prevented by use of
a simple strategy at the time of operation.5
Such a strategy was recently used by Cas-
tro and associates6; as a result, the inci-
dence of moderate-severe PPM in their
population was only 2.5%, instead of the
17% that would have occurred had this
prospective strategy not been used,
whereas operative mortality remained low
(1%). Extrapolating these findings to the
total number of aortic valve replacements
being performed each year in North Amer-
ica, it is estimated that approximately 1000
operative deaths could potentially be
avoided through use of such a strategy.
In this context, the conclusion of these
two articles with regard to the prevalence
of PPM and its consequences cannot be
accepted at face value, because the param-
eter used to define PPM is not valid to
characterize postoperative hemodynam-
ics.3 To the contrary, we still believe in the
“value of concentrating on better hemody-
namic performance”1 and that research
aimed at properly identifying PPM, as well
as preventing it, can significantly contrib-
ute to improved outcomes after aortic valve
surgery.
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Reply to the Editor:
We have long respected the excellent and
prolific work of Dumesnil and Pibarot, so it
is not surprising that we referred to their
publications in our articles. However, they
are unhappy in part with the way we have
interpreted (or misinterpreted) their
work,1,2 and in part with the surgical rec-
ommendations we based on survival data
from our multicenter meta-analysis,1 which
differ from their own, which were based
largely on functional prosthesis perfor-
mance data.
What We Studied
Survival
We studied the relation of geometric pros-
thesis size to time-related survival with
nine sources of data and nearly 70,000 pa-
tient-years of follow-up among 13,258 pa-
tients who underwent aortic valve replace-
ment with mechanical prostheses, stent-
